KHQ MD ALERT: New Skin Cancer Drug Approved - Spokane, North Idaho News & Weather KHQ.com

KHQ MD ALERT: New Skin Cancer Drug Approved

CNN.COM - Adults with metastatic basal cell cancer now have a new drug to help them battle the disease.

The Food and Drug Administration has approved Erivedge under the agency's priority review program. The program provides an expedited six-month review process for drugs that may result in major treatment advances.

Erivedge is for patients with advanced basal cell carcinoma  who are not candidates for radiation or surgery, or for those whose cancer has spread. BCC is the most common form of skin cancer in the country. It grows slowly and is generally curable.

The new drug inhibits a molecular pathway called the Hedgehog pathway, which is found in most basal cell cancers.

"Our understanding of molecular pathways involved in cancer, such as the Hedgehog pathway, has enabled the development of targeted drugs for specific diseases," said Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research. "This approach is becoming more common and will potentially allow cancer drugs to be developed more quickly. This is important for patients who will have access to more effective therapies with potentially fewer side effects."

This is the first FDA-approved treatment for metastatic BCC. It comes in pill form - a capsule that's taken once a day.

ccording to the drug's manufacturer, Genentech, an independent review of clinical studies found Erivedge shrank lesions in 43% of patients with locally advanced BCC and 30% in patients with metastatic BCC.

"Today's approval provides a new treatment for people with advanced basal cell carcinoma who, until now, had no approved medicines to help shrink disfiguring or potentially life-threatening lesions," said Dr. Hal Barron, chief medical officer and head, Global Product Development for Genentech.

Dr. Evan Lipson, and instructor of medical oncology at Johns Hopkins Kimmel Cancer Center has treated patients with the drug.

"Like most of the pathway therapy drugs that we are using these days, these drugs are remarkably successful compared to the chemotherapy drugs that have been available to us up until now," Lipson said. "The downside is that the effects of the drug on the tumor are not as long lasting as we would like and research is underway to develop ways to create longer lasting responses."

There are side effects , including muscle spasms, hair loss, weight loss, distorted sense of or loss of taste. Erivedge will come with a black box warning about the potential risk of death, and of severe birth defects to unborn babies. Pregnancy status must be verified before starting treatment.

According to Genentech, the drug will be available within two weeks.

  • Most Popular StoriesMost Popular StoriesMore>>

  • New York State illegally moving convicted sex offenders from prisons into group homes with the developmentally disabled

    New York State illegally moving convicted sex offenders from prisons into group homes with the developmentally disabled

    Thursday, September 20 2018 9:14 AM EDT2018-09-20 13:14:31 GMT
    Three State agencies are involved in placing convicted sex offenders in group homes or hiding this information from the families and the general public>>
    Three State agencies are involved in placing convicted sex offenders in group homes or hiding this information from the families and the general public>>
  • Cold Case: The Missing Wedding Guest

    Cold Case: The Missing Wedding Guest

    Sunday, September 23 2018 11:39 PM EDT2018-09-24 03:39:50 GMT

    STEVENS COUNTY, Wash. - It's been nearly two years since anyone has seen or heard from Paul Brazeau. He was last seen at his son's wedding. His brokenhearted family reached out to KHQ's Hayley Guenthner with a letter asking for his case to be featured in our Q6 Cold Case series. The day Paul vanished started out so wonderful. "It was a happy day," said Paul's aunt Georgine Glatt. 

    >>

    STEVENS COUNTY, Wash. - It's been nearly two years since anyone has seen or heard from Paul Brazeau. He was last seen at his son's wedding. His brokenhearted family reached out to KHQ's Hayley Guenthner with a letter asking for his case to be featured in our Q6 Cold Case series. The day Paul vanished started out so wonderful. "It was a happy day," said Paul's aunt Georgine Glatt. 

    >>
  • State defends no-jail sentence in Anchorage assault case

    State defends no-jail sentence in Anchorage assault case

    Sunday, September 23 2018 7:06 PM EDT2018-09-23 23:06:59 GMT

    ANCHORAGE, Alaska (AP) - The Alaska Department of Law stood by a judge’s sentence that calls for no jail time for an Anchorage man who authorities say offered a woman a ride and choked her until she was unconscious. Justin Schneider, 34, pleaded guilty to one count of felony assault in the case. A kidnapping charge was dropped as part of the plea deal. 

    >>

    ANCHORAGE, Alaska (AP) - The Alaska Department of Law stood by a judge’s sentence that calls for no jail time for an Anchorage man who authorities say offered a woman a ride and choked her until she was unconscious. Justin Schneider, 34, pleaded guilty to one count of felony assault in the case. A kidnapping charge was dropped as part of the plea deal. 

    >>
HD DOPPLER 6i
/